Charles Baker-Glenn,Mark Chambers,Bryan K. Chan,Anthony Estrada,Zachary Kevin Sweeney
申请号：
US13687429
公开号：
US08796296B2
申请日:
2012.11.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Compounds of the formula I:or pharmaceutically acceptable salts thereof,wherein A, X, R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinsons disease.
